CMMB - Chemomab Therapeutics Ltd.
1.88
0.050 2.660%
Share volume: 51,357
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.83
0.05
0.03%
Summary score
6%
Profitability
0%
Dept financing
6%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2019 - 2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-24.94%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
20.16%
Debt ratio change over timeo
0%
Current Ratio
4.83%
Quick Ratio
0%
Cash Position Ratio
2.97%
Short-term ratios 2022 - 2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-24.94%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
20.16%
Debt ratio change over timeo
0%
Current Ratio
4.83%
Quick Ratio
0%
Cash Position Ratio
2.97%
Last quarter ratios 2023
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-24.94%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
20.16%
Debt ratio change over time
0%
Current Ratio
4.83%
Quick Ratio
0%
Cash Position Ratio
2.97%
Performance ratios (change over 4 years) 2019 - 2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CMMB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 27.95% | 6.11% | -1.33% |
| Return on assets | -24.94% | 3.98% | 3.21% | 3.04% |
| Return on sales | 0% | 26.94% | 25.41% | 31.67% |
| Return on invested capital | 0% | 9.33% | 5.39% | 4.6% |
| Profitability | 0% | 96% | 60% | 56% |
| Total debt ratio | 20.16% | 85.77% | 60.65% | 95.31% |
| Debt ratio change over time | 0% | 8.23% | 11.4% | 310.12% |
| Dept financing | 5% | 23% | 17% | 50% |
| Current Ratio | 4.83% | 1.14% | 1.23% | 0.96% |
| Quick Ratio | 0% | 0.89% | 1% | 0.83% |
| Cash Position Ratio | 2.97% | 0.18% | 0.53% | 0.28% |
| Liquididy | 50% | 30% | 36% | 36% |
| Short-term ratios | CMMB | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.53% | 4.06% | 0% |
| Return on assets | -24.94% | 3.71% | 2.94% | 1.58% |
| Return on sales | 0% | 25.4% | 25.38% | 29.51% |
| Return on invested capital | 0% | 8.37% | 4.6% | 0% |
| Profitability | 0% | 97% | 63% | 36% |
| Total debt ratio | 20.16% | 79.51% | 59.32% | 88.85% |
| Debt ratio change over time | 0% | 7.88% | 7.34% | 0% |
| Dept financing | 6% | 47% | 40% | 25% |
| Current Ratio | 4.83% | 1.14% | 1.23% | 0.96% |
| Quick Ratio | 0% | 0.89% | 1% | 0.83% |
| Cash Position Ratio | 2.97% | 0.18% | 0.53% | 0.28% |
| Liquididy | 50% | 30% | 36% | 28% |